Pages that link to "Q44672509"
Jump to navigation
Jump to search
The following pages link to Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells (Q44672509):
Displaying 12 items.
- Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways (Q24646599) (← links)
- The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review) (Q28067149) (← links)
- Terpenoids as potential chemopreventive and therapeutic agents in liver cancer (Q35238085) (← links)
- Allylic structures in cancer drugs and body metabolites that control cell life and death (Q38089154) (← links)
- Anticancer activities of essential oils constituents and synergy with conventional therapies: a review (Q38211993) (← links)
- Prognostic Significance of Statin Use in Colorectal Cancer: A Systematic Review and Meta-Analysis (Q38536886) (← links)
- Synergistic Impact of d-δ-Tocotrienol and Geranylgeraniol on the Growth and HMG CoA Reductase of Human DU145 Prostate Carcinoma Cells (Q38709503) (← links)
- Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation (Q39539316) (← links)
- Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2. (Q40319745) (← links)
- Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells (Q42811138) (← links)
- Geraniol inhibits murine skin tumorigenesis by modulating COX-2 expression, Ras-ERK1/2 signaling pathway and apoptosis. (Q54499899) (← links)
- The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins (Q60920750) (← links)